secwatch.observer — SEC 8-K summary
======================================

Issuer:     RenovoRx, Inc. (RNXT)
CIK:        0001574094
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001493152-26-012058
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RenovoRx raises $10M via common stock and milestone warrants in oversubscribed offering
--------------------------------------------------------------------------------

- Raised ~$10M gross from sale of 8.4M shares, 2.2M pre-funded warrants, and 5.3M milestone warrants to 15 investors (including insiders).
- Milestone warrants (50% coverage) expire upon $1.5M quarterly product revenue or Mar 30, 2029; exercise price $1.751 (institutional), $1.933 (insiders).
- Proceeds to boost RenovoCath commercial rollout and fund Phase III TIGeR-PaC trial to full enrollment by mid-2026.
- Insider participation at $1.0288/share vs $0.938 for institutions to comply with Nasdaq pricing rules.
- Company must file resale registration within 30 days; liquidated damages of up to 10% of subscription amount if delayed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574094/000149315226012058/0001493152-26-012058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574094/000149315226012058/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-012058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer